The efficacy of telemedical care for heart failure: A meta-analysis of randomized controlled trials - 12/08/21
Abstract |
Introduction |
The efficacy of telemedical care for the treatment of heart failure remains controversial. We conduct a systematic review and meta-analysis to explore the impact of telemedical care on heart failure.
Methods |
We search PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through October 2020 for randomized controlled trials (RCTs) assessing the effect of telemedical care on heart failure. This meta-analysis is performed using the random-effect model.
Results |
Four RCTs involving 2516 patients are included in the meta-analysis. Overall, compared with control group for heart failure, telemedical care demonstrates no significant influence on cardiovascular death (OR = 0.74; 95% CI = 0.54 to 1.00; P = 0.05), mortality (OR = 0.86; 95% CI = 0.61 to 1.20; P = 0.38), hospital stay for heart failure (SMD = -1.57; 95% CI = -6.31 to 3.16; P = 0.52) or hospital stay for any readmission (SMD = -0.65; 95% CI = -8.98 to 7.68; P = 0.88), but can reduce the days lost due to death or heart failure readmissions (SMD = -6.50; 95% CI = -8.44 to −4.56; P < 0.00001).
Conclusions |
Telemedical care may provide no additional benefits for heart failure.
Le texte complet de cet article est disponible en PDF.Keywords : Telemedical care, Heart failure, Randomized controlled trials, Meta-analysis
Plan
Vol 47
P. 1-5 - septembre 2021 Retour au numéro
Article précédent
- Outcomes for in-hospital cardiac arrest for COVID-19 patients at a rural hospital in Southern California
- Rahul V. Nene, Nicole Amidon, Christian A. Tomaszewski, Gabriel Wardi, Andrew Lafree
- Cerebral venous thrombosis: Diagnosis and management in the emergency department setting
- Anthony Spadaro, Kevin R. Scott, Alex Koyfman, Brit Long
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?